Get the app
Adam Koppel
Partner at Bain Capital Life Sciences and experienced life sciences investor with an MD and PhD in neuroscience and an MBA, leading Bain's growth of its life sciences team and focused on growth equity and scaled biotech deals.
Best podcasts with Adam Koppel
Ranked by the Snipd community
Jan 9, 2026
• 37min
Ep. 100 - Adam Koppel on Why Private Equity Is Moving Deeper Into Biotech and What Comes Next
chevron_right
Adam Koppel, a Partner at Bain Capital Life Sciences, dives into the evolving landscape of private equity in biopharma. He outlines why traditional PE shied away from biotech and how the sector has matured to require large-scale investments. Koppel shares Bain’s unique approach to prioritizing deals and maintaining capital discipline, even as average check sizes soar. He discusses the sustainability of this trend, raising concerns over development costs and company proliferation, while remaining optimistic about private financings and IPO readiness.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app